BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:STRO-004 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of STRO-004\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07227168-2744@assetmemo.bio
DTSTAMP:20261121T004510Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:STRO-004: Phase 1 readout est. (NCT07227168)
DESCRIPTION:STRO-004\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Stud
 y of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer\nEstim
 ated primary completion: December 2027. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/stro-004#upcoming-events\nRegistry record: https://clin
 icaltrials.gov/study/NCT07227168
URL:https://assetmemo.bio/drug/stro-004#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
